"Repeat breast cancer surgeries due to residual disease remain a significant clinical, health, and economic burden," said Perimeter CEO, Adrian Mendes. "Claire's FDA approval marks a major milestone ...
DUBLIN--(BUSINESS WIRE)--The "Portable Diagnostic Imaging - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Portable Diagnostic Imaging was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results